Ono Pharmaceutical Co., Ltd. (OPHLF)
USD 10.89
(0.0%)
USD 10.89
(0.0%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 | 48.62 Billion JPY | 8.51% |
| 2023 | 44.81 Billion JPY | 7.17% |
| 2022 | 41.81 Billion JPY | 6.81% |
| 2021 | 39.15 Billion JPY | 18.98% |
| 2020 | 32.9 Billion JPY | 0.26% |
| 2019 | 32.82 Billion JPY | 4.89% |
| 2018 | 31.29 Billion JPY | 23.51% |
| 2017 | 25.33 Billion JPY | 9.05% |
| 2016 | 23.23 Billion JPY | -9.97% |
| 2015 | 25.8 Billion JPY | 6.49% |
| 2014 | 24.23 Billion JPY | 3.52% |
| 2013 | 23.4 Billion JPY | 25.61% |
| 2012 | 18.63 Billion JPY | 42.85% |
| 2011 | 13.04 Billion JPY | -10.8% |
| 2010 | 14.62 Billion JPY | 45.42% |
| 2009 | 10.05 Billion JPY | 0.86% |
| 2008 | 9.97 Billion JPY | 7.22% |
| 2007 | 9.3 Billion JPY | -0.49% |
| 2006 | 9.34 Billion JPY | 3.53% |
| 2005 | 9.02 Billion JPY | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 FY | 48.62 Billion JPY | 8.51% |
| 2024 Q2 | 48.58 Billion JPY | -3.58% |
| 2024 Q1 | 50.39 Billion JPY | 12.44% |
| 2024 Q3 | 46.41 Billion JPY | -4.47% |
| 2024 Q4 | 48.62 Billion JPY | 4.77% |
| 2023 FY | 44.81 Billion JPY | 7.17% |
| 2023 Q2 | 43.88 Billion JPY | 2.92% |
| 2023 Q1 | 42.64 Billion JPY | 1.97% |
| 2023 Q4 | 44.81 Billion JPY | -0.04% |
| 2023 Q3 | 44.83 Billion JPY | 2.15% |
| 2022 Q3 | 39.03 Billion JPY | 1.15% |
| 2022 FY | 41.81 Billion JPY | 6.81% |
| 2022 Q2 | 38.59 Billion JPY | -2.17% |
| 2022 Q4 | 41.81 Billion JPY | 7.12% |
| 2022 Q1 | 39.45 Billion JPY | 0.76% |
| 2021 Q4 | 39.15 Billion JPY | 1.37% |
| 2021 FY | 39.15 Billion JPY | 18.98% |
| 2021 Q1 | 34.57 Billion JPY | 5.06% |
| 2021 Q3 | 38.62 Billion JPY | 4.0% |
| 2021 Q2 | 37.13 Billion JPY | 7.42% |
| 2020 FY | 32.9 Billion JPY | 0.26% |
| 2020 Q1 | 31.34 Billion JPY | -4.49% |
| 2020 Q2 | 30.95 Billion JPY | -1.25% |
| 2020 Q3 | 31.97 Billion JPY | 3.29% |
| 2020 Q4 | 32.9 Billion JPY | 2.92% |
| 2019 Q4 | 32.82 Billion JPY | -2.74% |
| 2019 Q3 | 33.74 Billion JPY | 4.4% |
| 2019 Q2 | 32.32 Billion JPY | 1.12% |
| 2019 Q1 | 31.96 Billion JPY | 2.15% |
| 2019 FY | 32.82 Billion JPY | 4.89% |
| 2018 Q3 | 30.44 Billion JPY | 7.25% |
| 2018 FY | 31.29 Billion JPY | 23.51% |
| 2018 Q1 | 26.73 Billion JPY | 5.52% |
| 2018 Q4 | 31.29 Billion JPY | 2.77% |
| 2018 Q2 | 28.39 Billion JPY | 6.2% |
| 2017 Q3 | 24.56 Billion JPY | -4.71% |
| 2017 FY | 25.33 Billion JPY | 9.05% |
| 2017 Q4 | 25.33 Billion JPY | 3.14% |
| 2017 Q2 | 25.77 Billion JPY | 5.89% |
| 2017 Q1 | 24.34 Billion JPY | 4.79% |
| 2016 Q3 | 22.84 Billion JPY | -10.58% |
| 2016 Q1 | 25.79 Billion JPY | -0.03% |
| 2016 Q2 | 25.54 Billion JPY | -0.97% |
| 2016 Q4 | 23.23 Billion JPY | 1.71% |
| 2016 FY | 23.23 Billion JPY | -9.97% |
| 2015 Q2 | 27.74 Billion JPY | 1.68% |
| 2015 Q3 | 26.35 Billion JPY | -5.0% |
| 2015 FY | 25.8 Billion JPY | 6.49% |
| 2015 Q1 | 27.28 Billion JPY | 12.59% |
| 2015 Q4 | 25.8 Billion JPY | -2.08% |
| 2014 Q2 | 25.13 Billion JPY | 0.85% |
| 2014 Q4 | 24.23 Billion JPY | -0.56% |
| 2014 Q1 | 24.91 Billion JPY | 6.45% |
| 2014 Q3 | 24.36 Billion JPY | -3.03% |
| 2014 FY | 24.23 Billion JPY | 3.52% |
| 2013 Q4 | 23.4 Billion JPY | 7.21% |
| 2013 Q3 | 21.83 Billion JPY | 2.64% |
| 2013 Q1 | 22.66 Billion JPY | 21.62% |
| 2013 Q2 | 21.27 Billion JPY | -6.15% |
| 2013 FY | 23.4 Billion JPY | 25.61% |
| 2012 FY | 18.63 Billion JPY | 42.85% |
| 2012 Q2 | 13.58 Billion JPY | -0.72% |
| 2012 Q1 | 13.68 Billion JPY | 4.91% |
| 2012 Q4 | 18.63 Billion JPY | 23.09% |
| 2012 Q3 | 15.14 Billion JPY | 11.42% |
| 2011 FY | 13.04 Billion JPY | -10.8% |
| 2011 Q1 | 13.85 Billion JPY | -5.27% |
| 2011 Q2 | 14.16 Billion JPY | 2.22% |
| 2011 Q3 | 12.91 Billion JPY | -8.8% |
| 2011 Q4 | 13.04 Billion JPY | 1.01% |
| 2010 Q3 | 13.98 Billion JPY | 4.27% |
| 2010 Q4 | 14.62 Billion JPY | 4.58% |
| 2010 FY | 14.62 Billion JPY | 45.42% |
| 2010 Q2 | 13.41 Billion JPY | 0.0% |
| 2009 Q4 | 10.05 Billion JPY | 3.7% |
| 2009 FY | 10.05 Billion JPY | 0.86% |
| 2009 Q3 | 9.69 Billion JPY | 0.0% |
| 2008 FY | 9.97 Billion JPY | 7.22% |
| 2007 FY | 9.3 Billion JPY | -0.49% |
| 2006 FY | 9.34 Billion JPY | 3.53% |
| 2005 FY | 9.02 Billion JPY | 0.0% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| AstraZeneca PLC | 5.41 Billion USD | -797.82% |
| Bristol-Myers Squibb Company PFD CONV 2 | 2.66 Billion USD | -1726.784% |
| CSPC Pharmaceutical Group Limited | 442.43 Million USD | -10891.307% |
| Clarus Therapeutics Holdings, Inc. | 14.21 Million USD | -342020.445% |
| Novartis AG | 5.91 Billion USD | -722.408% |
| PT Kalbe Farma Tbk. | 451.27 Million USD | -10675.796% |